Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival

Cancer Letters

Volumn 213, Issue 1, 2004, Pages 91-98

  Farhadieh, Ross D ^a,d   Smee, Robert ^b   Ow, Kim ^a   Yang, Jia Lin ^c   Russell, Pamela J ^a   Crouch, Roger ^b   Jackson, Paul ^a   Jacobson, Ian V ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Oncol Res Ctr Prnc Wales H   (Australia)

^d Sydney Adult and Children's ENT Ctr   (Australia)

Author keywords

KAI1 metastasis suppressor gene; Oral carcinoma; Prognosis

Indexed keywords

CD82 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EVALUATION; FEMALE; HAZARD ASSESSMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SUPPRESSOR GENE; TISSUE SECTION; TREATMENT FAILURE;

AGED; ANTIGENS, CD; ANTIGENS, SURFACE; CARCINOMA; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RADIOTHERAPY, ADJUVANT;

EID: 4344616837     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.004     Document Type: Article

References (26)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics. CA-Cancer J. Clin. 51:2001;15-36
2. Mamella G., Pamprik J., Luboiski B. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am. J. Surg. 168:1994;494-498
3. O'Brien C.J., Lahr C.J., Soong S. Surgical treatment of early stage carcinoma of the oral tongue. Head Neck Surg. 8:1986;401-408
4. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma: clinico-pathological applications. Oral. Oncol. 36:2000;404-413
5. Odintsova E., Sugiura D., Berdichevski F. Attenuation of EGF receptor signalling by a metastasis suppressor, the Tetraspanin CD82/KAI1. Curr. Biol. 10:2000;1009-1012
6. Zhang X.A., Lane W.S., Charrin S., Rubenstein E., Liu L. EW12/PGRL Associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. Cancer Res. 63:2003;2665-2674
7. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Issacs J.T., Barret J.C. A metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 268:1995;884-886
8. Yu Y., Yang J.L., Markovic B., Jackson P., Yardley G., Barrett J., Russell P.J. Loss of KAI1 messenger RNA expression in both high grade and invasive human bladder cancers. Clin. Cancer Res. 3:1997;1045-1049
9. Lombardi D.P., Geradts J., Foley J.F., Chiao C., Lamb P.W., Barrett J.C. Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res. 59:1999;5724-5731
10. Schindl M., Birner P., Breitenecker G., Oberhuber G. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Gynecol. Oncol. 83:2001;244-248
11. Liu F.-S., Dong J.-T., Chen J.-T., Hsieh Y.-T., Ho E.S.-C., Hung M.-J., et al. KAI1 metastasis suppressor protein is down regulated during the progression of human endometrial cancer. Clin. Cancer Res. 9:2003;1393-1398
12. Yang X., Welch D.R., Phillips K.K., Weissman B.E., Wei L.L. A putative marker for metastatic potential in human breast cancer. Cancer Lett. 119:1997;149-155
13. Miyazaki T., Kato H., Shitara Y., Yoshioka M., Tajima K., Masuda N., et al. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal and gastric Cancers. Cancer. 89:2000;955-962
14. Imai Y., Sasaki T., Shinagawa S., Akimoto K., Fujiabayashi T. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance. Oral Oncol. 38:2002;557-561
15. Uzawa K., Ono K., Suzuki H., Tanaka C., Yakushiji T., Yamamoto N., Yokoe H., Tanzawa H. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis. Clin. Cancer Res. 8:2002;828-835
16. Mannion B.A., Berdichevski F., Kraeft S.K., Chan L.B., Hemler M.E. Transmembrane-4 Family Proteins CD81 (TAPA-1), CD82, CD63 and CD53 Specifically Associate with Integrins α4β1 (CD49d/CD29). J. Immunol. 157:1996;2039-2047
17. Lagaudriere-Gesbert C., Lebel-Binay S., Hubeau C., Fradelizi D., Conjeaud H. Signalling through the Tetraspanin CD82 triggers its association with cytoskeleton leading to sustained morphological changes and T cell activation. Eur. J. Immunol. 28:1998;4332-4344
18. Lebel-Binay S., Lagaudriere-Gesbert C., Fradelizi D., Conjeaud H. CD82 member of the Tetra-Span-Membrane protein family, is a costimulaltory protein for T cell activation. J. Immunol. 155:1995;101-110
19. Hemler M.E., Mannion B.A., Berdichevski F. Association of TM4SF proteins with Integrins: relevance to cancer. Biochem. Biophys. Act. 1287:1996;67-71
20. Mashimo T., Watabe M., Hirota S., Hosobe S., Mirua K., Tegtmeyer P.J., et al. The expression of the KAI1 gene, a tumour metastasis suppressor is directly activated by p53. Proc. Natl Acad. Sci. 95:1998;11307-11311
21. Mashimo T., Badyopadhyay A., Goodarzi G., Watabe M., Pai S.K., Gross S.C., Watabe K. Activation of the tumour metastasis suppressor gene, KAI1 by etoposide is mediated by p53 and c-Jun genes. Biochem. Biophys. Res. Com. 274:2000;370-376
22. Dong J.T., Suzuki H., Pin S.S., Bova S., Schalken J.A., Isaacs W.B., et al. Down-regulation of the KAI1 metastasis gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 56:1996;4387-4390
23. Kawana Y., Komiya A., Ueda T., Nihei N., Kuramochi H., Suzuki H., et al. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced prostate cancer. The Prostate. 32:1997;205-213
24. Tagawa K., Arihiro K., Takeshima Y., Hiyama E., Yamasaki M., Inai K. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma. Jpn. J. Cancer Res. 90:1999;970-976
25. Jackson P., Millar D., Kingsley E., Yardley G., Ow K., Clark S., P J. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. Cancer Lett. 157:2000;169-176
26. Duriez C., Falette D., Cortes U., Moyret-Lalle C., Puisieux A. Absence of p53-Dependent Induction of the metastatic suppressor KAI1 gene after DNA damage. Oncogene. 19:2000;2461-2464